Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
223
days
Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases
AuthorsBhupendra Raj Giri; Jamie Erin Spahn; Rawidh Alsaidalani; Beatriz Behrend-Keim; Mohammed Bhia; Jailen Haley Doyle; Matthew Joseph Herpin; Rex Corbin Moore; Nila Sangeetha Murali; Arifenur Safak; Hugh David Charles Smyth
Affiliations1. Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, USA; 2. Austin, USA; 3. Department of Chemistry, The University of Texas at Austin, Austin, USA
216
days
Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering
AuthorsSha Li; Ying Gao; Cheng-Gang Zhu; Jian-Jun Li
Affiliations1. Cardiometabolic Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
75
days
Chronic Ocular Surface Pain: A Missing Member of the Chronic Overlapping Pain Conditions?
AuthorsJonghoon Chang; Alex Hattenhauer; Luisa Saccaro; Ferida Mamatkazina; Elizabeth Felix; Lindsey De Lott; Anat Galor
Affiliations1. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, USA; 2. Surgical Services, Miami Veterans Affairs Medical Center, Miami, USA; 3. Bogomolets National Medical University, Kyiv, Ukraine; 4. Research Services, Miami Veterans Affairs Medical Center, Miami, USA; 5. Department of Physical Medicine and Rehabilitation, University of Miami Miller School of Medicine, Miami, USA; 6. Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, USA
7
days
Rovadicitinib: First Approval
AuthorsHannah A. Blair
Affiliations1. Springer Nature, Auckland, New Zealand
23
days
Icotrokinra: First Approval
AuthorsSusan J. Keam
Affiliations1. Springer Nature, Auckland, New Zealand
82
days
Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians
AuthorsKevin F. Boehnke; Niloufar Pouyan; Jacob S. Aday
Affiliations1. Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, USA; 2. Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, USA; 3. Neuroscience Graduate Program, University of Michigan, Ann Arbor, USA
18
days
Navepegritide: First Approval
AuthorsConnie Kang
Affiliations1. Springer Nature, Auckland, New Zealand
48
days
Misuse of Pregabalin and Gabapentin: A Second Systematic Review Update
AuthorsKirk E. Evoy; Daija Drain; Justin Pedigo; Jordan R. Covvey; Olivia Ramey
Affiliations1. College of Pharmacy, The University of Texas at Austin, San Antonio, USA; 2. School of Pharmacy, Duquesne University, Pittsburgh, USA
350
days
Sex-Biased Pharmacotherapeutic Disparities in Hypertension
AuthorsSerge Yaacoub; Charles Bardawil; Ryan Yammine; Ali H. Dakroub; Ali H. Eid
Affiliations1. Center for Cancer and Immunology Research, Children’s National Medical Center, Washington, USA; 2. Department of Cardiothoracic Surgery, Wake Forest University School of Medicine, Winston-Salem, USA; 3. Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, Division of Endocrinology and Metabolism, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; 4. Mayo Clinic, Jacksonville, USA; 5. Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days